Back

Peripheral ultrafiltration: the PURE-HF trial and first insights from the prospective Gentle-UF registry.

28 May 2018 (13:20 - 13:33)
Organised by:
Congress Presentation Part of: PURE-HF and the future of decongestive therapies Acute Heart Failure HFA Premium Access Heart Failure 2018

About the speaker

Photo
Doctor Maria Rosa Costanzo

Midwest Cardiovascular Institute, Naperville (United States of America)

6 More presentations in this session

Presentation thumbnail
Welcome and introduction.
Professor F. Ruschitzka (Zurich, CH)
Presentation thumbnail
Current concepts of decongestion with diuretics in heart failure.
Professor M. Metra (Milan, IT)
Presentation thumbnail
Strategies for safe and effective decongestion in acutely decompensated heart failure with impaired diuretic responsiveness - Novel drugs.
Professor G. Filippatos (Athens, GR)
Presentation thumbnail
Strategies for safe and effective decongestion in acutely decompensated heart failure with impaired diuretic responsiveness - Novel device-based therapies.
Professor P. Ponikowski (Wroclaw, PL)
Presentation thumbnail
Putting it all together.
Professor F. Ruschitzka (Zurich, CH)

Access the full session

Session thumbnail
PURE-HF and the future of decongestive therapies

The Event

Event poster

Heart Failure 2018

28 May 2018 13:20 CET
You may be interested in
thumbnail
Congress Presentation
Therapeutic approach in heart failure with poor diuretic response. Peripheral ultrafiltration vs. conventional treatment
20 May 2023
thumbnail
Congress Session
Hottest trials and trial updates (1)
17 May 2025
thumbnail
Congress Presentation
UF-CARE, ultrafiltration in type 2 cardiorenal syndrome
9 May 2026
thumbnail
Congress Session
Challenges in acute heart failure
18 May 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources